Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by donmayneon Jun 02, 2021 6:34am
72 Views
Post# 33309164

RE:Viemed up to 558 Employees:

RE:Viemed up to 558 Employees:In the past six months the staff increse is about 11%. (or 22% per year). Stellar indeed but it appears to fall short of what is necessary to grow revenue or earnings at a 40% or even 30% per annum.

Odd, but the last quarterly conference call had management somewhat defensive and almost embarassed about the earnings performance and phantom share expense. 

During the CC, they boasted how they wanted to wait for a big deal rather than multiple small deals. The biggest deal possible is a company in the same business that can grow at 40%.  Well then start investing the cash windfall in Viemed?  

I have little doubt the company will be successful but will it be successful enough for shareholders or just successful enough for management to achieve their personal financial goals. They have certainly done well personally in the last few years and have no reason to change their style of self dealing.  Their windfall profits of last quarter sits on the books without purpose earning 1%. If they indeed felt they could grow organically at 40 percent, those monies would be invested in share buybacks.  It does seem that they prefer to keep the money to protect future personal financial goals and to engage in big talk, nothing more. 

Disappointing that they do nothing to control the volatility of the share price. The volatility will continue to haunt the company in the future.

















<< Previous
Bullboard Posts
Next >>